Cite
HARVARD Citation
Fosgerau, K. et al. (n.d.). The novel GLP‐1‐gastrin dual agonist, ZP3022, increases β‐cell mass and prevents diabetes in db/db mice. Diabetes, obesity & metabolism. 15 (1), pp. 62-71. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fosgerau, K. et al. (n.d.). The novel GLP‐1‐gastrin dual agonist, ZP3022, increases β‐cell mass and prevents diabetes in db/db mice. Diabetes, obesity & metabolism. 15 (1), pp. 62-71. [Online].